Call Now: +92 21 32635837|editor@medicalreviewintl.com
Facebook

Oxford

Home/Tag:Oxford
15 08, 2014

Ten Years of Tamoxifen Reduces Breast Cancer Recurrences, Improves Survival

2017-04-26T12:34:59+00:00

For some women with Breast Cancer, taking adjuvant tamoxifen  for 10 years after primary treatment leads to a greater reduction in breast cancer recurrences and deaths than taking the drug for only 5 years, according to the results of a large international clinical trial. The findings from the ATLAS trial—presented at the San Antonio Breast Cancer Symposium  (SABCS) and published in The [...]

15 02, 2014

New genetic regions linked with type 2 diabetes identified

2017-04-26T12:35:02+00:00

Largest study yet of diabetes genetics brings in data from 20 countries on four continents Seven new genetic regions associated with type 2 diabetes have been identified in the largest study to date of the genetic basis of the disease. DNA data was brought together from more than 48,000 patients and 139,000 healthy controls from [...]

15 12, 2011

Malaria during Pregnancy: New study assesses risks during first trimester

2017-04-26T12:35:23+00:00

The largest ever study to assess the effects of malaria and its treatment in the first trimester of pregnancy has shown that the disease significantly increases the risk of miscarriage but that treating with antimalarial drugs is relatively safe and reduces this risk. In the study, carried out at the Shoklo Malaria Research Unit (SMRU) [...]

15 09, 2011

Oxford Study: Vitamin A supplements could save the lives of 600,000 infants a year

2011-10-11T18:49:45+00:00

An international study suggests that giving vitamin A supplements to children in low and middle income countries could significantly cut rates of mortality, illnesses and blindness amongst those below the age of five. Researchers from the University of Oxford and Pakistan’s Aga Khan University have shown that vitamin A supplements reduce mortality amongst children from [...]